Logo wahanariau.com
  • Berita
  • Peristiwa
  • Politik
  • Ekonomi
  • Teknologi
  • Otomotif
  • Olahraga
  • Gaya Hidup
  • Travel
  • More
    • Video
    • Media OutReach
    • Globenewswire
    • Advertorial
    • Pilihan Editor
    • Terpopuler
    • Indeks
Berita Politik Peristiwa Ekonomi Otomotif Olahraga Teknologi Gaya Hidup Travel Video Media OutReach Globenewswire Advertorial Pilihan Editor Terpopuler Indeks
  • Berita
  • Peristiwa
  • Politik
  • Ekonomi
  • Teknologi
  • Otomotif
  • Olahraga
  • Gaya Hidup
  • Travel
  • More
    • Video
    • Media OutReach
    • Globenewswire
    • Advertorial
    • Pilihan Editor
    • Terpopuler
    • Indeks
  1. Spec

Spec

Index
Globenewswire

SPEC Resumes Global Collaboration with Companies on U.S. BIS Entity List

Kamis, 05 Juni 2025 - 14:37:45 Wib

Terpopuler

Index
1

SOUEAST Accelerates Global Expansion and Elevates Its International Profile
Dibaca: 111 Kali

2

PhotonPay Raises $40M Series C to Scale Its Stablecoin-Centric Financial OS
Dibaca: 103 Kali

3

Vinhomes Green Paradise to Enter Global Vote for the Future of Urban Living
Dibaca: 100 Kali

4

SeABank announces Sustainable Finance Framework
Dibaca: 101 Kali

5

Hainan economic, trade delegation visits Hong Kong for investment promotion, 2 cooperation memoranda signed
Dibaca: 100 Kali

Terkini

Index
Citeline Provides LEO Pharma with R&D Data via AI Integration
29 Oktober 2026
  • ZJLD Group Returns to Hong Kong Wine & Dine Festival 2026

    ZJLD Group Returns to Hong Kong Wine & Dine Festival 2026

    29 Oktober 2026
  • TestMu AI Launches One-Click Katalon Migration to Test Manager, With Every Supported Case Authored as a KaneAI Test

    TestMu AI Launches One-Click Katalon Migration to Test Manager, With Every Supported Case Authored as a KaneAI Test

    29 Oktober 2026
  • BlackLine Expands into Europe’s Trusted Cloud Market with S3NS

    BlackLine Expands into Europe’s Trusted Cloud Market with S3NS

    29 Oktober 2026
  • Junshi Biosciences Announces the Completion of First Patient Dosing in the Phase 3 Clinical Trial of JS207 in Combination with JS007 for the First-Line Treatment of Advanced Hepatocellular Carcinoma

    Junshi Biosciences Announces the Completion of First Patient Dosing in the Phase 3 Clinical Trial of JS207 in Combination with JS007 for the First-Line Treatment of Advanced Hepatocellular Carcinoma

    29 Oktober 2026
  • PONTI4D: Link Slot Gacor Mudah Maxwin Hari Ini Dengan Situs Pola Gampang Menang Terbaik 2026
  • hiatoto
  • slot thailand
  • situs gacor
  • slot maxwin
  • slot gacor 2026
Company Profile
Tentang Kami Redaksi Kode Etik Jurnalistik Pedoman Media Siber Disclaimer Kontak Kami
Logo wahanariau.com
Follow Us


© Copyright 2023 WahanaRiau.com. All Rights Reserved By Delapan Media